Insulin and type 1 diabetes: immune connections

被引:29
|
作者
Culina, Sloboda [1 ,2 ]
Brezar, Vedran [1 ,2 ]
Mallone, Roberto [1 ,2 ,3 ]
机构
[1] Hop St Vincent de Paul, INSERM, U986, DeAR Lab Avenir, F-75674 Paris 14, France
[2] Paris Descartes Univ, Fac Med, Paris, France
[3] Hop Hotel Dieu, AP HP, Serv Diabetol, Paris, France
关键词
BETA-CELL FUNCTION; ANTIBODY STANDARDIZATION PROGRAM; THYMIC EPITHELIAL-CELLS; ALTERED-PEPTIDE LIGAND; AUTOREACTIVE T-CELLS; ORAL INSULIN; NOD MICE; 1ST-DEGREE RELATIVES; GENE-EXPRESSION; DENDRITIC CELLS;
D O I
10.1530/EJE-12-0693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin is the hormone produced by pancreatic beta-cells, with a central role in carbohydrate and fat metabolism. Together with its precursors preproinsulin and proinsulin, insulin is also a key target antigen (Ag) of the autoimmune islet destruction leading to type 1 diabetes. Being recognized by both autoantibodies (aAbs) and autoreactive T cells, insulin plays a triggering role, at least in rodent models, in diabetes pathogenesis. It is expressed not only by beta-cells but also in the thymus, where it plays a major role in central tolerance mechanisms. We will summarize current knowledge concerning insulin, its role in beta-cell autoimmunity as initial target Ag, its recognition by aAbs and autoreactive T cells, and the detection of these immune responses to provide biomarkers for clinical trials employing insulin as an immune modulatory agent. European Journal of Endocrinology 168 R19-R31
引用
收藏
页码:R19 / R31
页数:13
相关论文
共 50 条
  • [31] Pancreatic β-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes
    Harrison, LC
    Honeyman, MC
    Steele, CE
    Stone, NL
    Sarugeri, E
    Bonifacio, E
    Couper, E
    Couper, JJ
    Colman, PG
    DIABETES CARE, 2004, 27 (10) : 2348 - 2355
  • [32] Insulin administration triggers autoimmune type 1 diabetes and insulin allergy in a patient with type 2 diabetes
    Makino, Hideichi
    Nakamura, Mai
    Nishida, Wataru
    Imagawa, Akihisa
    Hanafusa, Toshiaki
    Onuma, Hiroshi
    Osawa, Haruhiko
    DIABETES, 2006, 55 : A280 - A280
  • [33] Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes
    Devendra, D
    Paronen, J
    Moriyama, H
    Miao, D
    Eisenbarth, GS
    Liu, E
    JOURNAL OF AUTOIMMUNITY, 2004, 23 (01) : 17 - 26
  • [34] Direct insulin algorithm for type 1 diabetes
    Santoso, L
    Mareels, IMY
    MODELLING AND CONTROL IN BIOMEDICAL SYSTEMS 2003 (INCLUDING BIOLOGICAL SYSTEMS), 2003, : 495 - 499
  • [35] Combination therapies with insulin in type 1 diabetes
    Gallwitz, Baptist
    DIABETOLOGE, 2021, 17 (07): : 761 - 768
  • [36] Insulin Administration for People with Type 1 diabetes
    Boiroux, Dimitri
    Finan, Daniel Aaron
    Poulsen, Niels Kjolstad
    Madsen, Henrik
    Jorgensen, John Bagterp
    21ST EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, 2011, 29 : 1558 - 1562
  • [37] Severe lipoatrophy with insulin in type 1 diabetes
    Ma, Xiaolan
    Lv, Haihong
    Li, Qi
    Shen, Jianguo
    JOURNAL OF DERMATOLOGY, 2012, 39 (06): : 578 - 579
  • [38] Standard insulin treatment of type 1 diabetes
    Chaitanya, Krishna
    AFRICAN JOURNAL OF DIABETES MEDICINE, 2019, 27 (01):
  • [39] Are insulin pumps underutilized in type 1 diabetes? No
    Schade, David S.
    Valentine, Virginia
    DIABETES CARE, 2006, 29 (06) : 1453 - 1455
  • [40] ADJUNCTIVE THERAPY WITH INSULIN IN TYPE 1 DIABETES
    Garg, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A3 - A3